The first case of a patient with neutropenia and giant-cell arteritis treated with rituximab

被引:0
作者
B. Mayrbaeurl
M. Hinterreiter
S. Burgstaller
M. Windpessl
J. Thaler
机构
[1] General Hospital,Fourth Department of Internal Medicine
[2] General Hospital,First Department of Internal Medicine
来源
Clinical Rheumatology | 2007年 / 26卷
关键词
Systemic Lupus Erythematosus; Neutropenia; Giant Cell Arteritis; Idiopathic Thrombocytopenic Purpura; Tumor Necrosis Factor Inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1597 / 1598
页数:1
相关论文
共 37 条
[1]  
Lawrence RC(1998)Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States Arthritis Rheum 41 778-799
[2]  
Helmick CG(2003)Giant-cell arteritis and polymyalgia rheumatica Ann Intern Med 139 505-515
[3]  
Arnett FC(1996)Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis Ann rheum Dis 55 218-223
[4]  
Deyo RA(2001)Combined treatment of giant-cell arteritis with methotrexat and prednisone. A randomized, double-blind, placebo-controlled trial Ann Intern Med 134 106-114
[5]  
Felson DT(2001)T cell activation in rheumatoid synovium is B cell dependent J Immunol 167 4710-4718
[6]  
Giannini EH(2003)The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets Curr Opin Rheumatol 15 246-252
[7]  
Weyand CM(2004)Efficacy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis N Eng J Med 350 2572-2581
[8]  
Goronzy JJ(2005)Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis Ann Rheum Dis 64 1099-1100
[9]  
van der Veen MJ(undefined)undefined undefined undefined undefined-undefined
[10]  
Dinant HJ(undefined)undefined undefined undefined undefined-undefined